As filed with the Securities and Exchange Commission on March 6, 2023 

Registration No. 333-_____                                  

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-8

 

REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OF 1933

 

Quanterix Corporation

(Exact name of registrant as specified in its charter)

 

Delaware 20-8957988
(State or other jurisdiction of incorporation or
organization)
(I.R.S. Employer Identification No.)
   
900 Middlesex Turnpike  
Billerica, MA 01821
(Address of Principal Executive Offices) (Zip Code)

 

2017 Employee Stock Purchase Plan 

2017 Employee, Director and Consultant Equity Incentive Plan 

(Full title of the plans)

 

Dr. Masoud Toloue 

President and Chief Executive Officer 

Quanterix Corporation 

900 Middlesex Turnpike 

Billerica, MA 01821 

(617) 301-9400
(Name, address and telephone number, including area code, of agent for service)

 

Copies to:

 

Catherine A. Dargan, Esq.

David H. Engvall, Esq.
Covington & Burling LLP

One CityCenter
850 Tenth Street, N.W.
Washington, D.C. 20001

(202) 662-6000

Laurie Churchill
General Counsel
Quanterix Corporation
900 Middlesex Turnpike
Billerica, MA 01821
(617) 301-9400

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer x
Non-accelerated filer ¨ Smaller reporting company ¨
  Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

 

 

 

 

 

 

EXPLANATORY NOTE

 

This Registration Statement registers an aggregate of 1,488,696 additional shares of common stock, par value $0.001 per share (“Common Stock”), of Quanterix Corporation (the “Company” or the “Registrant”) under the Registrant’s 2017 Employee, Director and Consultant Equity Incentive Plan and 372,174 additional shares of Common Stock under the Registrant’s 2017 Employee Stock Purchase Plan, representing increases in the number of shares of Common Stock reserved for issuance under each such plan, in each case effective January 1, 2023 by operation of the “evergreen” provision contained in the applicable plan.

 

Pursuant to General Instruction E to Form S-8 under the Securities Act of 1933, as amended, the contents of the Registrant’s Registration Statements on Form S-8 filed with the U.S. Securities and Exchange Commission (the “Commission”) on March 19, 2018 (File No. 333-223771), May 10, 2019 (File No. 333-231373), August 5, 2020 (File No. 333-240420), May 12, 2021 (File No. 333-256032) and May 10, 2022 (File No. 333-264836) are incorporated by reference and made part of this Registration Statement. Any items in such registration statements not expressly changed hereby shall be as set forth in such registration statements.

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3. Incorporation of Documents by Reference.

 

The Company is subject to the informational and reporting requirements of Sections 13(a), 14 and 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) and in accordance therewith files reports, proxy statements and other information with the Commission. The following documents, which are on file with the Commission, are incorporated in this Registration Statement by reference:

 

(a) The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Commission on March 6, 2023 (File No. 001-38319);

 

(b) All other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the document referred to in (a) above (other than the portions of those documents not deemed to be filed); and

 

(c) The description of Common Stock filed as Exhibit 4.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the Commission on March 13, 2020 (File No. 001-38319).

 

All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment that indicates that all securities offered hereby have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of the filing of such documents.

 

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

 

 

 

 

Item 5. Interests of Named Experts and Counsel.

 

The validity of the issuance of the shares of Common Stock registered under this Registration Statement has been passed upon for the Registrant by Covington & Burling LLP.

 

Item 8. Exhibits.

 

Exhibit No. Description
   
3.1 Amended and Restated Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed on December 15, 2017).
   
3.2 Restated Bylaws of the Registrant (incorporated herein by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K filed on December 15, 2017).
   
4.1 Form of Common Stock Certificate of the Registrant (incorporated herein by reference to Exhibit 4.1 of the Registrant’s Registration Statement on Form S-1 filed on November 9, 2017).
   
5.1* Opinion of Covington and Burling LLP.
   
23.1* Consent of Covington and Burling LLP (included in Exhibit 5.1).
   
23.2* Consent of Ernst & Young LLP.
   
24.1* Power of Attorney (included on the signature page of this Registration Statement).
   
99.1 2017 Employee Stock Purchase Plan (incorporated herein by reference to Exhibit 99.5 of the Registrant’s Registration Statement on Form S-8 filed on March 19, 2018).
   
99.2 2017 Employee, Director and Consultant Equity Incentive Plan (incorporated herein by reference to Exhibit 10.2.1 of the Registrant’s Registration Statement on Form S-1/A filed on November 27, 2017).
   
107* Filing Fees Exhibit.

 

* Filed herewith.

 

 

 

 

SIGNATURES

 

The Registrant. Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Billerica, Commonwealth of Massachusetts, on March 6, 2023.

 

  QUANTERIX CORPORATION
   
  By: /s/ Masoud Toloue
    Masoud Toloue
    President and Chief Executive Officer

 

 

 

 

SIGNATURES AND POWER OF ATTORNEY

 

Each of the directors and officers of Quanterix Corporation whose signature appears below hereby severally constitutes and appoints Masoud Toloue and Michael Doyle and each of them singly, their true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them singly, for them and in their name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8 of Quanterix Corporation, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting to said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in or about the premises, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them or their substitute may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature   Title   Date

 

/s/ Masoud Toloue, Ph.D.

  President, Chief Executive Officer and Director (principal executive officer)  

 

March 6, 2023

Masoud Toloue, Ph.D.    
         
/s/ Michael A. Doyle   Chief Financial Officer (principal financial officer and principal accounting officer)   March 6, 2023
Michael A. Doyle    
         
/s/ Martin D. Madaus, Ph.D.   Chairman   March 6, 2023
Martin D. Madaus, Ph.D.        
         
/s/ Brian J. Blaser   Director   March 6, 2023
Brian J. Blaser        
         
/s/ Keith L. Crandell   Director   March 6, 2023
Keith L. Crandell        
         
/s/ Karen A. Flynn   Director   March 6, 2023
Karen A. Flynn        
         
  Director    
Sarah E. Hlavinka        
         
  Director    
Paul M. Meister        
         
/s/ Laurie J. Olson   Director   March 6, 2023
Laurie J. Olson        
         
/s/ David R. Walt, Ph.D.   Director   March 6, 2023
David R. Walt, Ph.D.        

 

 

 

Exhibit 5.1

 

 

 

March 6, 2023

 

Quanterix Corporation 

900 Middlesex Turnpike 

Billerica, MA 01821

 

Ladies and Gentlemen:

 

We have acted as counsel to Quanterix Corporation, a Delaware corporation (the “Company”), in connection with the registration by the Company under the Securities Act of 1933, as amended (the “Act”), of 1,860,870 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), consisting of 1,488,696 shares of Common Stock (the “Incentive Plan Shares”) issuable under the Company’s 2017 Employee, Director and Consultant Equity Incentive Plan (the “Incentive Plan”) and 372,174 shares of Common Stock (the “ESPP Shares” and, together with the Incentive Plan Shares, the “Shares”) issuable under the Company’s 2017 Employee Stock Purchase Plan (the “2017 ESPP”), pursuant to the Registration Statement on Form S-8 filed with the Securities and Exchange Commission on the date hereof (such registration statement is referred to herein as the “Registration Statement”).

 

We have reviewed such corporate records, certificates and other documents, and such questions of law, as we have considered necessary or appropriate for the purposes of this opinion. We have assumed that all signatures are genuine, that all documents submitted to us as originals are authentic and that all copies of documents submitted to us conform to the originals.

 

We have relied as to certain matters on information obtained from public officials, officers of the Company and other sources believed by us to be responsible.

 

Based upon the foregoing, we are of the opinion that the Incentive Plan Shares and the ESPP Shares have been duly authorized and, when issued and paid for in accordance with the terms of the Incentive Plan and the 2017 ESPP, respectively, and any individual agreements relating to such Shares, the Shares will be validly issued, fully paid and non-assessable.

 

We are members of the bar of the District of Columbia. We do not express any opinion herein on any laws other than the General Corporation Law of the State of Delaware and reported judicial decisions interpreting these laws.

 

We hereby consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act.

 

Very truly yours,  
 
/s/ Covington & Burling LLP  

 

 

 

Exhibit 23.2

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2017 Employee Stock Purchase Plan and the 2017 Employee, Director and Consultant Equity Incentive Plan of Quanterix Corporation of our reports dated March 6, 2023, with respect to the consolidated financial statements of Quanterix Corporation and the effectiveness of internal control over financial reporting of Quanterix Corporation included in its Annual Report (Form 10-K) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.

 

/s/ Ernst & Young LLP  
 
Boston, Massachusetts   
March 6, 2023  

 

 

 

EXHIBIT 107

 

Calculation of Filing Fee Tables

 

Form S-8 

(Form Type)

 

Quanterix Corporation

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security

Type

  Security Class Title 

Fee

Calculation

Rule

 

Amount

Registered(1)

  

Proposed
Maximum Offering

Price Per Unit(2)

  

Maximum
Aggregate

Offering Price(2)

 

Fee

Rate

 

Amount of

Registration

Fee

 
Equity  Common Stock, par value $0.001 per share, to be issued under the 2017 Employee, Director and Consultant Equity Incentive Plan  Other   1,488,696 (3  $11.10   $16,524,525.60  $110.20 per $1,000,000  $1,821.01 
Equity  Common Stock, par value $0.001 per share, to be issued under the 2017 Employee Stock Purchase Plan  Other   372,174 (4)   $11.10   $4,131,131.40  $110.20 per $1,000,000  $455.26 
Total Offering Amounts         $20,655,657.00     $2,276.27 
Total Fee Offsets (5)                  $ 
Net Fee Due                   $2,276.27 

 

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the registrant’s Common Stock that become issuable in respect of such securities by reason of any stock dividend, stock split, recapitalization or other similar transaction.
(2) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act, and based upon the average of the high and low prices of the registrant’s Common Stock as reported on The Nasdaq Global Market on February 28, 2023.
(3) Represents additional shares of the registrant’s Common Stock reserved for issuance under the registrant’s 2017 Employee, Director and Consultant Equity Incentive Plan.
(4) Represents additional shares of the registrant’s Common Stock reserved for issuance under the registrant’s 2017 Employee Stock Purchase Plan.
(5) The registrant does not have any fee offsets.